William C. Stewart

The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension.

W. C. Stewart, K. Latham, D. Day, 2001, American journal of ophthalmology.

Intraocular Pressure, Safety and Quality of Life in Glaucoma Patients Switching to Latanoprost from Adjunctive and Monotherapy Treatments

W. C. Stewart, F. Haverkamp, S. Wuensch, 2003, European journal of ophthalmology.

Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma. Night Study Group.

P. Netland, H. Weiss, W. C. Stewart, 1997, American journal of ophthalmology.

Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model

W. C. Stewart, M. Mychaskiw, J. Stewart, 2009, Eye.

Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma

A. Konstas, W. C. Stewart, V. Kozobolis, 2004, Eye.